Is your clinic still relying on the "test-and-wait" game for acute infections?

Fever, cough, diarrhea—in daily practice, overlapping symptoms make distinguishing viral from bacterial infections nearly impossible on clinical presentation alone.

The traditional pathway—sequential testing and waiting days for cultures—comes with a heavy cost:

❌ Delayed Diagnosis: Turnaround times drag from hours into days.

❌ Missed Pathogens: Single-target assays frequently miss co-infections.

❌ Empiric Over-treatment: Diagnostic uncertainty fuels the global AMR crisis.

❌ Prolonged Stays: Unclear etiology delays targeted treatment and discharge.

Enter Multiplex Molecular Detection: One Sample. One Run. Comprehensive Answers.

Modern multiplex PCR panels detect 10+ pathogens—including viruses, bacteria, and resistance markers—from a single specimen in ~1 hour.

📉 The evidence speaks for itself: Rapid multiplex testing reduces antibiotic prescription rates by 30–50% in confirmed viral cases, shortens ED stays by over 2 hours, and boosts clinician confidence above 75%.

At Chenhui Medical, we engineered our Molecular POCT platforms to bridge the gap between lab-grade accuracy and point-of-care speed:

🧬 Multi-Disc Platform (Up to 28-plex): Tailored for severe infection scenarios in ICUs and inpatient settings, where comprehensive pathogen mapping is life-saving.

⚡Flex-Disc Platform (Up to 16-plex): Optimized for outpatient clinics and ED workflows, balancing diagnostic breadth with operational simplicity.

With AMR projected to claim 10 million lives annually by 2050, precision diagnostics aren't just an upgrade—they're a necessity. The future isn't about running more tests; it's about running the right test, once.

💬 To our healthcare & lab partners: What has been the biggest challenge or breakthrough in integrating multiplex POCT into your clinical workflow? Let's discuss below!